2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole

DB03354ExperimentalSmall molecule

2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole: Overview.

Chemical structure of 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole
Formula / weight
C9H14N2O6 · 246.2173 g/mol (avg)

Resolves to

Compound
ChEMBLCHEMBL540929ChEBI44722PubChem657043
Structure
InChIKeyHCSFWJQLIPWUFZ-JAJWTYFOSA-NSMILES[H][C@]1(CO)O[C@@]([H])(C2=NN=C(C)O2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Targets
P11217PYGM

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In